Literature DB >> 27110918

Control of glioblastoma tumorigenesis by feed-forward cytokine signaling.

Arezu Jahani-Asl1,2,3,4,5, Hang Yin3,6,7,8, Vahab D Soleimani5,9, Takrima Haque4,5, H Artee Luchman10, Natasha C Chang3,6, Marie-Claude Sincennes3,6, Sidharth V Puram1, Andrew M Scott11, Ian A J Lorimer3,12, Theodore J Perkins3,6,12, Keith L Ligon13,14, Samuel Weiss10, Michael A Rudnicki3,6, Azad Bonni1,2.   

Abstract

EGFRvIII-STAT3 signaling is important in glioblastoma pathogenesis. Here, we identified the cytokine receptor OSMR as a direct target gene of the transcription factor STAT3 in mouse astrocytes and human brain tumor stem cells (BTSCs). We found that OSMR functioned as an essential co-receptor for EGFRvIII. OSMR formed a physical complex with EGFRvIII, and depletion of OSMR impaired EGFRvIII-STAT3 signaling. Conversely, pharmacological inhibition of EGFRvIII phosphorylation inhibited the EGFRvIII-OSMR interaction and activation of STAT3. EGFRvIII-OSMR signaling in tumors operated constitutively, whereas EGFR-OSMR signaling in nontumor cells was synergistically activated by the ligands EGF and OSM. Finally, knockdown of OSMR strongly suppressed cell proliferation and tumor growth of mouse glioblastoma cells and human BTSC xenografts in mice, and prolonged the lifespan of these mice. Our findings identify OSMR as a critical regulator of glioblastoma tumor growth that orchestrates a feed-forward signaling mechanism with EGFRvIII and STAT3 to drive tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27110918      PMCID: PMC4984527          DOI: 10.1038/nn.4295

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  44 in total

1.  Overexpression of the oncostatin M receptor in cervical squamous cell carcinoma cells is associated with a pro-angiogenic phenotype and increased cell motility and invasiveness.

Authors:  David M Winder; Anasuya Chattopadhyay; Balaji Muralidhar; Julien Bauer; William R English; Xiao Zhang; Konstantina Karagavriilidou; Ian Roberts; Mark R Pett; Gillian Murphy; Nicholas Coleman
Journal:  J Pathol       Date:  2011-09-26       Impact factor: 7.996

2.  Snail regulates MyoD binding-site occupancy to direct enhancer switching and differentiation-specific transcription in myogenesis.

Authors:  Vahab D Soleimani; Hang Yin; Arezu Jahani-Asl; Hong Ming; Christel E M Kockx; Wilfred F J van Ijcken; Frank Grosveld; Michael A Rudnicki
Journal:  Mol Cell       Date:  2012-07-05       Impact factor: 17.970

3.  EGFR and EGFRvIII in glioblastoma: partners in crime.

Authors:  Gelareh Zadeh; Krishna P L Bhat; Kenneth Aldape
Journal:  Cancer Cell       Date:  2013-10-14       Impact factor: 31.743

4.  Interaction of Hsp90 with the nascent form of the mutant epidermal growth factor receptor EGFRvIII.

Authors:  Sylvie J Lavictoire; Doris A E Parolin; Alex C Klimowicz; John F Kelly; Ian A J Lorimer
Journal:  J Biol Chem       Date:  2002-12-05       Impact factor: 5.157

5.  Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons.

Authors:  Makiko Nagai; Diane B Re; Tetsuya Nagata; Alcmène Chalazonitis; Thomas M Jessell; Hynek Wichterle; Serge Przedborski
Journal:  Nat Neurosci       Date:  2007-04-15       Impact factor: 24.884

6.  Essential role of STAT3 for embryonic stem cell pluripotency.

Authors:  R Raz; C K Lee; L A Cannizzaro; P d'Eustachio; D E Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

7.  Isolation of cancer stem cells from adult glioblastoma multiforme.

Authors:  Xiangpeng Yuan; James Curtin; Yizhi Xiong; Gentao Liu; Sebastian Waschsmann-Hogiu; Daniel L Farkas; Keith L Black; John S Yu
Journal:  Oncogene       Date:  2004-12-16       Impact factor: 9.867

8.  Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.

Authors:  Lene Uhrbom; Chengkai Dai; Joseph C Celestino; Marc K Rosenblum; Gregory N Fuller; Eric C Holland
Journal:  Cancer Res       Date:  2002-10-01       Impact factor: 12.701

Review 9.  Malignant astrocytic glioma: genetics, biology, and paths to treatment.

Authors:  Frank B Furnari; Tim Fenton; Robert M Bachoo; Akitake Mukasa; Jayne M Stommel; Alexander Stegh; William C Hahn; Keith L Ligon; David N Louis; Cameron Brennan; Lynda Chin; Ronald A DePinho; Webster K Cavenee
Journal:  Genes Dev       Date:  2007-11-01       Impact factor: 11.361

10.  EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma.

Authors:  Qi-Wen Fan; Christine K Cheng; W Clay Gustafson; Elizabeth Charron; Petra Zipper; Robyn A Wong; Justin Chen; Jasmine Lau; Christiane Knobbe-Thomsen; Michael Weller; Natalia Jura; Guido Reifenberger; Kevan M Shokat; William A Weiss
Journal:  Cancer Cell       Date:  2013-10-14       Impact factor: 31.743

View more
  43 in total

1.  Helping EGFR inhibition to block cancer.

Authors:  Rolf Warta; Christel Herold-Mende
Journal:  Nat Neurosci       Date:  2017-07-26       Impact factor: 24.884

Review 2.  Old player, new partner: EGFRvIII and cytokine receptor signaling in glioblastoma.

Authors:  Genaro R Villa; Paul S Mischel
Journal:  Nat Neurosci       Date:  2016-05-26       Impact factor: 24.884

3.  The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation.

Authors:  Juan M Adrian-Segarra; Natalie Schindler; Praveen Gajawada; Holger Lörchner; Thomas Braun; Jochen Pöling
Journal:  J Biol Chem       Date:  2018-03-06       Impact factor: 5.157

4.  Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression.

Authors:  Dou Yu; Omar F Khan; Mario L Suvà; Biqin Dong; Wojciech K Panek; Ting Xiao; Meijing Wu; Yu Han; Atique U Ahmed; Irina V Balyasnikova; Hao F Zhang; Cheng Sun; Robert Langer; Daniel G Anderson; Maciej S Lesniak
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-10       Impact factor: 11.205

Review 5.  Role of Chimeric Antigen Receptor T Cell Therapy in Glioblastoma Multiforme.

Authors:  Vishal Jindal
Journal:  Mol Neurobiol       Date:  2018-03-09       Impact factor: 5.590

Review 6.  Multidimensional communication in the microenvirons of glioblastoma.

Authors:  Marike L Broekman; Sybren L N Maas; Erik R Abels; Thorsten R Mempel; Anna M Krichevsky; Xandra O Breakefield
Journal:  Nat Rev Neurol       Date:  2018-08       Impact factor: 42.937

Review 7.  Role of STAT3 in Genesis and Progression of Human Malignant Gliomas.

Authors:  Zangbéwendé Guy Ouédraogo; Julian Biau; Jean-Louis Kemeny; Laurent Morel; Pierre Verrelle; Emmanuel Chautard
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

8.  EGFRvIII-Stat5 Signaling Enhances Glioblastoma Cell Migration and Survival.

Authors:  Alison Roos; Harshil D Dhruv; Sen Peng; Landon J Inge; Serdar Tuncali; Michael Pineda; Nghia Millard; Zachary Mayo; Jennifer M Eschbacher; Joseph C Loftus; Jeffrey A Winkles; Nhan L Tran
Journal:  Mol Cancer Res       Date:  2018-05-03       Impact factor: 5.852

Review 9.  Targeting epidermal growth factor receptor co-dependent signaling pathways in glioblastoma.

Authors:  Feng Liu; Paul S Mischel
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2017-09-11

Review 10.  A glial blueprint for gliomagenesis.

Authors:  Dylan Laug; Stacey M Glasgow; Benjamin Deneen
Journal:  Nat Rev Neurosci       Date:  2018-07       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.